Akinetic mutism-a serious complication to tacrolimus-based GVHD prophylaxis.
J E
JE
Najera
A
A
Alousi
M
M
De Lima
S O
SO
Ciurea
D000405:Akinetic Mutism / Q000209:etiology* / Q000517:prevention & control; D016903:Drug Monitoring; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000503:physiopathology* / Q000628:therapy; D009679:Nuclear Family; D033581:Stem Cell Transplantation / Q000009:adverse effects; D016559:Tacrolimus / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016559:Tacrolimus